Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 21


Full dose neoadjuvant FOLFIRINOX is associated with prolonged survival in patients with locally advanced pancreatic adenocarcinoma.

Khushman M, Dempsey N, Cudris Maldonado J, Loaiza-Bonilla A, Velez M, Carcas L, Dammrich D, Hurtado-Cordovi J, Parajuli R, Pollack T, Harwood AP, Macintyre J, Tzeng CD, Merchan JR, Restrepo MH, Akunyili II, Ribeiro A, Narayanan G, Portelance L, Sleeman D, Levi JU, Rocha Lima CM, Hosein PJ.

Pancreatology. 2015 Sep 12. pii: S1424-3903(15)00635-3. doi: 10.1016/j.pan.2015.08.010. [Epub ahead of print]


Percutaneous Approach to Irreversible Electroporation of the Pancreas: Miami Protocol.

Venkat S, Hosein PJ, Narayanan G.

Tech Vasc Interv Radiol. 2015 Sep;18(3):153-8. doi: 10.1053/j.tvir.2015.06.006. Epub 2015 Jun 18.


A cohort study evaluating the role of surgery for lung metastases from colorectal cancer.

Socola F, Nguyen DM, Ochoa RE, Rocha Lima CM, Hosein PJ.

Anticancer Res. 2015 Jun;35(6):3431-5.


Updated survival analysis of two sequential prospective trials of R-MACLO-IVAM followed by maintenance for newly diagnosed mantle cell lymphoma.

Hosein PJ, Sandoval-Sus JD, Goodman D, Arteaga AG, Reis I, Hoffman J, Stefanovic A, Rosenblatt JD, Lossos IS.

Am J Hematol. 2015 Jun;90(6):E111-6. doi: 10.1002/ajh.23996. Epub 2015 Apr 2.


Phase II study of (90)Y Ibritumomab tiuxetan (Zevalin) in patients with previously untreated marginal zone lymphoma.

Lossos IS, Fabregas JC, Koru-Sengul T, Miao F, Goodman D, Serafini AN, Hosein PJ, Stefanovic A, Rosenblatt JD, Hoffman JE.

Leuk Lymphoma. 2015 Jun;56(6):1750-5. doi: 10.3109/10428194.2014.975801. Epub 2014 Nov 20.


A phase II, open-label, multicenter study to evaluate the antitumor efficacy of CO-1.01 as second-line therapy for gemcitabine-refractory patients with stage IV pancreatic adenocarcinoma and negative tumor hENT1 expression.

Li D, Pant S, Ryan DP, Laheru D, Bahary N, Dragovich T, Hosein PJ, Rolfe L, Saif MW, LaValle J, Yu KH, Lowery MA, Allen A, O'Reilly EM.

Pancreatology. 2014 Sep-Oct;14(5):398-402. doi: 10.1016/j.pan.2014.07.003. Epub 2014 Jul 18.


Percutaneous irreversible electroporation for the treatment of colorectal cancer liver metastases with a proposal for a new response evaluation system.

Hosein PJ, Echenique A, Loaiza-Bonilla A, Froud T, Barbery K, Rocha Lima CM, Yrizarry JM, Narayanan G.

J Vasc Interv Radiol. 2014 Aug;25(8):1233-1239.e2. doi: 10.1016/j.jvir.2014.04.007. Epub 2014 May 24.


LMO2 and BCL6 are associated with improved survival in primary central nervous system lymphoma.

Lossos C, Bayraktar S, Weinzierl E, Younes SF, Hosein PJ, Tibshirani RJ, Sutton Posthumus J, DeAngelis LM, Raizer J, Schiff D, Abrey L, Natkunam Y, Lossos IS.

Br J Haematol. 2014 Jun;165(5):640-8. doi: 10.1111/bjh.12801. Epub 2014 Feb 26. Review.


A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era.

Hosein PJ, Maragulia JC, Salzberg MP, Press OW, Habermann TM, Vose JM, Bast M, Advani RH, Tibshirani R, Evens AM, Islam N, Leonard JP, Martin P, Zelenetz AD, Lossos IS.

Br J Haematol. 2014 May;165(3):358-63. doi: 10.1111/bjh.12753. Epub 2014 Jan 27.


Successful use of Trastuzumab with anthracycline-based chemotherapy followed by trastuzumab maintenance in patients with advanced HER2-positive gastric cancer.

Palacio S, Loaiza-Bonilla A, Kittaneh M, Kyriakopoulos C, Ochoa RE, Escobar M, Arango B, Restrepo MH, Merchan JR, Rocha Lima CM, Hosein PJ.

Anticancer Res. 2014 Jan;34(1):301-6.


Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma.

Narayanan G, Hosein PJ, Arora G, Barbery KJ, Froud T, Livingstone AS, Franceschi D, Rocha Lima CM, Yrizarry J.

J Vasc Interv Radiol. 2012 Dec;23(12):1613-21. doi: 10.1016/j.jvir.2012.09.012.


Progressive multifocal leukoencephalopathy following treatment with bendamustine and rituximab.

Warsch S, Hosein PJ, Morris MI, Teomete U, Benveniste R, Chapman JR, Lossos IS.

Int J Hematol. 2012 Aug;96(2):274-8. doi: 10.1007/s12185-012-1118-6. Epub 2012 Jun 9.


A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma.

Hosein PJ, Macintyre J, Kawamura C, Maldonado JC, Ernani V, Loaiza-Bonilla A, Narayanan G, Ribeiro A, Portelance L, Merchan JR, Levi JU, Rocha-Lima CM.

BMC Cancer. 2012 May 29;12:199. doi: 10.1186/1471-2407-12-199.


A phase II trial of nab-Paclitaxel as second-line therapy in patients with advanced pancreatic cancer.

Hosein PJ, de Lima Lopes G Jr, Pastorini VH, Gomez C, Macintyre J, Zayas G, Reis I, Montero AJ, Merchan JR, Rocha Lima CM.

Am J Clin Oncol. 2013 Apr;36(2):151-6. doi: 10.1097/COC.0b013e3182436e8c.


A retrospective study evaluating the efficacy and safety of bendamustine in the treatment of mantle cell lymphoma.

Warsch S, Hosein PJ, Maeda LS, Alizadeh AA, Lossos IS.

Leuk Lymphoma. 2012 Jul;53(7):1299-305. doi: 10.3109/10428194.2011.649476. Epub 2012 Jan 31.


A multicenter phase II study of darinaparsin in relapsed or refractory Hodgkin's and non-Hodgkin's lymphoma.

Hosein PJ, Craig MD, Tallman MS, Boccia RV, Hamilton BL, Lewis JJ, Lossos IS.

Am J Hematol. 2012 Jan;87(1):111-4. doi: 10.1002/ajh.22232. Epub 2011 Nov 12. No abstract available.


Utility of positron emission tomography scans in mantle cell lymphoma.

Hosein PJ, Pastorini VH, Paes FM, Eber D, Chapman JR, Serafini AN, Alizadeh AA, Lossos IS.

Am J Hematol. 2011 Oct;86(10):841-5. doi: 10.1002/ajh.22126. Epub 2011 Aug 22.


Severe colitis associated with docetaxel use: A report of four cases.

Carrion AF, Hosein PJ, Cooper EM, Lopes G, Pelaez L, Rocha-Lima CM.

World J Gastrointest Oncol. 2010 Oct 15;2(10):390-4. doi: 10.4251/wjgo.v2.i10.390.


The evolving role of F-FDG PET scans in patients with aggressive non-Hodgkin's lymphoma.

Hosein PJ, Lossos IS.

European J Clin Med Oncol. 2010 Feb;2(1):131-138.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk